Brexanolone | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Brexanolone
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Brexanolone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

7 API Suppliers, 2 USDMF, 3 NDC API, 6 Listed Suppliers, $ API Reference Price

7 API Suppliers
2 USDMF
3 NDC API
6 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 1 FDA Orange Book, 1 Listed Dossiers

2 FDF Dossiers
1 FDA Orange Book
1 Listed Dossiers

DIGITAL CONTENT

24 NEWS #PharmaBuzz

24 NEWS #PharmaBuzz

PATENTS & EXCLUSIVITIES

8 US Patents, 2 US Exclusivities

8 US Patents
2 US Exclusivities

$ API Ref.Price (USD/KG) : 236,107 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8SAGE THERAP

filter Patent Number Reset all filters

8 All

01 17635773

02 18410077

03 19200088

04 19750822

05 110117951

06 110251894

07 110322139

08 110940156

filter API Patent Reset all filters

8 All

01 8Blank

filter FDF Patent Reset all filters

8 All

01 6Y

02 2Blank

filter Expiration Date Reset all filters

8 All

01 52029-03-13

02 12033-01-23

03 12033-11-27

04 12037-03-08

Product Main Page

01

SAGE THERAP

The Generic Rx Session

Not Confirmed

SAGE THERAP

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-03-08

BREXANOLONE

US Patent Number : 10940156

Drug Substance Claim :

Drug Product Claim :

Application Number : 211371

Patent Use Code : U-2552

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-03-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

SAGE THERAP

The Generic Rx Session

Not Confirmed

SAGE THERAP

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-11-27

BREXANOLONE

US Patent Number : 10251894

Drug Substance Claim :

Drug Product Claim :

Application Number : 211371

Patent Use Code : U-2552

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-11-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

SAGE THERAP

The Generic Rx Session

Not Confirmed

SAGE THERAP

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

BREXANOLONE

US Patent Number : 8410077

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211371

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

SAGE THERAP

The Generic Rx Session

Not Confirmed

SAGE THERAP

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

BREXANOLONE

US Patent Number : 9200088

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211371

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

SAGE THERAP

The Generic Rx Session

Not Confirmed

SAGE THERAP

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

BREXANOLONE

US Patent Number : 9750822

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211371

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

SAGE THERAP

The Generic Rx Session

Not Confirmed

SAGE THERAP

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

BREXANOLONE

US Patent Number : 7635773

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211371

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

SAGE THERAP

The Generic Rx Session

Not Confirmed

SAGE THERAP

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-01-23

BREXANOLONE

US Patent Number : 10322139

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211371

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

SAGE THERAP

The Generic Rx Session

Not Confirmed

SAGE THERAP

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

BREXANOLONE

US Patent Number : 10117951

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211371

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!